Illumina, INC Form 4 insider transactions

Michael C Sullivan, Chief Commercial Officer of Illumina, Inc., reported multiple transactions in common stock on August 5, 2026.

Keith A. Meister, a Director of Illumina, Inc., sold 741,127 shares of common stock on August 4, 2026.

Scott M Davies, Chief Legal Officer of Illumina, Inc., sold 615 shares of common stock on July 30, 2026 for $200.00 per share.

Illumina, Inc. Director Keith Meister acquired 142 shares of common stock as part of his board and committee cash retainer fees for the second quarter of 2026.

Illumina Director Scott B. Ullem received 167 shares of common stock as payment for his board and committee fees for the second quarter of 2026.

Illumina Chief Legal Officer Scott M. Davies reported a transaction involving the sale of 615 shares of common stock.

Illumina's SVP, Chief People Officer, Patricia Leckman, reported the sale of 783 shares of common stock on June 5, 2026, under a pre-arranged 10b5-1 trading plan.

Illumina SVP, Chief People Officer Patricia Leckman reported transactions involving the sale of common stock on June 2, 2026.

Keith Meister of Corvex Management disclosed the sale of over 700,000 shares of Illumina, Inc. following the termination of equity swaps.

Illumina Chief Legal Officer Scott M. Davies reported a transaction involving the sale of common stock.

Scott D. Ericksen, VP and Chief Accounting Officer of Illumina, Inc., reported transactions involving the sale of company common stock.

Director Keith Meister filed an amendment to a previous Form 4 to correct the beneficial ownership balance of Illumina, Inc. common stock.

Director David P. King was granted 2,072 restricted stock units of Illumina, Inc. common stock.

Illumina, Inc. director Susan E. Siegel was granted 2,072 restricted stock units as part of her director compensation.

Illumina, Inc. director Scott B. Ullem was granted 2,072 restricted stock units as part of his director compensation.

Director Philip W. Schiller acquired 2,072 restricted stock units of Illumina, Inc. as part of an equity grant.

Illumina, Inc. director Anna Richo was granted 2,072 restricted stock units as part of her compensation package.

Illumina, Inc. director Keith Meister was granted 2,072 restricted stock units as part of his director compensation.

Illumina, Inc. director Scott Gottlieb was granted 2,072 restricted stock units as part of his director compensation.

Director Caroline Dorsa acquired 2,072 restricted stock units and disposed of 1,512 shares of Illumina common stock.

Keith Meister of Corvex Management reduced his indirect beneficial ownership in Illumina, Inc. through a series of equity swap terminations and open market stock sales.

Director Keith Meister of Corvex Management reports the partial termination of equity swaps linked to Illumina, Inc. common stock.

Jakob Wedel Christensen, SVP of Strategy and Corp Development at Illumina, Inc., reported the sale of 700 shares and the withholding of 233 shares for tax obligations.

Illumina, Inc. Director Scott B. Ullem acquired shares of common stock as part of his retainer fees for the first quarter of 2026.

Illumina, Inc. director Keith Meister received 161 shares of common stock as payment for his board and committee fees for the first quarter of 2026.

Illumina's Chief Legal Officer, Scott M. Davies, sold 1,336 shares of common stock at $116.18 per share on February 20, 2026, under a pre-arranged 10b5-1 trading plan.

Illumina Director Scott Gottlieb purchased 200 shares of common stock at $117.81, increasing his direct beneficial ownership to 12,723 shares.

Illumina Director Scott B. Ullem acquired 212 shares of common stock at $117.6298 per share, increasing his direct beneficial ownership to 8,601 shares.

Illumina's Chief Legal Officer, Scott M. Davies, sold 323 shares of common stock for $136.09 per share on December 12, 2025, under a Rule 10b5-1 plan.

Illumina's Senior Vice President of Strategy and Corporate Development, Jakob Wedel Christensen, reported the sale of 856 shares of common stock in early December 2025, primarily for tax obligations and open market sales.